AN2 Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics. The company's initial candidate includes epetraborole, which is phase 3 clinical trial as a once-daily oral treatment for patients with non-tuberculous mycobacterial lung...
35 insider purchases on record · latest filing 2026-09-02.
Insiders have also filed 103 sale transactions at ANTX.